Skip to main content

CRCM LP

Position in RNA — Atrium Therapeutics, Inc.

CIK 1483234 SAN FRANCISCO, CA

Position in RNA

as of Jun 30, 2026 · filed Aug 18, 2026
Position Value
$8,628,699
New position
Shares Held
641,539
first reported quarter
Ownership
3.75%
of shares outstanding
% of Portfolio
5.85%
of 13F equity value
Holder Rank
#5
of 155 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 0% Shared 100% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CRCM LP holds $9,339,739 across 2 Biotechnology names. RNA ranks #1 (92.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RNA
Atrium Therapeutics, Inc.
This page
641,539 $8,628,699

All Filings in RNA

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $8,628,699 641,539